Macrogenics reported $-24955000 in EBIT for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Amgen AMGN:US USD 2.66B 71M
AstraZeneca AZN:LN USD 2.26B 427M
Biogen BIIB:US USD 872.1M 68.8M
Bristol Myers Squibb BMY:US USD 2.74B 461M
Daiichi Sankyo 4568:JP JPY 61.2B 26.82B
Eli Lilly And LLY:US USD 1.95B 294.9M
Genmab GEN:DC DKK 1.93B 684M
Gilead Sciences GILD:US USD 2.81B 784M
Immunogen IMGN:US USD -77429000 16.38M
Johnson & Johnson JNJ:US USD 6.27B 572M
Karyopharm Therapeutics KPTI:US USD -30839000 12.07M
Macrogenics MGNX:US USD -24955000 16.85M
Merk MRK:US USD 5.56B 156M
Mirati Therapeutics MRTX:US USD -186443000 9.24M
Pfizer PFE:US USD 9.7B 2.43B
Regeneron Pharmaceuticals REGN:US USD 1.22B 83.2M
Roche Holding ROG:VX 11.54B 2.84B
Seattle Genetics SGEN:US USD -192805000 59.69M
Xencor XNCR:US USD -38348000 10.35M